Department of Orthodontics, Faculty of Dentistry, The University of Hong Kong, Hong Kong SAR, China.
Cytotherapy. 2013 Jun;15(6):712-25. doi: 10.1016/j.jcyt.2013.01.012. Epub 2013 Mar 7.
The aim of this study was to engineer sizable three-dimensional cartilage-like constructs using stem cells isolated from human dental pulp stem cells (DPSCs).
Human DPSCs were isolated from teeth extracted for orthodontic treatment and enriched further using immuno-magnetic bead selection for stem cell marker CD146. Chondrogenic lineage differentiation of DPSCs induced using recombinant transforming growth factor β3 (TGFβ3) was verified by pellet culture. Because the use of recombinant proteins is associated with rapid degradation and difficult in vivo administration, we constructed the recombinant adeno-associated viral vector encoding human TGFβ3 and determined the best multiplicity of infection for DPSCs. Transduced DPSCs were seeded on poly-l-lactic acid/polyethylene glycol (PLLA/PEG) electrospun fiber scaffolds demonstrating proper attachment, proliferation and viability as shown by scanning electron microscopy micrographs and CCK-8 cell counting kit. Scaffolds seeded with DPSCs were implanted in the back of nude mice.
Transduced DPSCs highly expressed human TGFβ3 for up to 48 days and expressed chondrogenic markers collagen IIa1, Sox9 and aggrecan, as verified by immunohistochemistry and messenger RNA (mRNA). Immunohistochemistry for TGFβ3/DPSC constructs (n = 5/group) showed cartilage-like matrix formation with glycosaminoglycans. In vivo constructs with TGFβ3/DPSCs showed higher collagen type II and Sox9 mRNA expression relative to non-transduced DPSC constructs (n = 5/group). Western blot analysis confirmed this expression pattern on the protein level (n = 3/group).
Immuno-selected DPSCs can be successfully differentiated toward chondrogenic lineage, while expressing the chondrogenic inducing factor. Seeded on PLLA/PEG electrospun scaffold, human DPSCs formed three-dimensional cartilage constructs that could prove useful in future treatment of cartilage defects.
本研究旨在使用从人牙髓干细胞(DPSC)中分离的干细胞来构建大规模的三维软骨样构建体。
从因正畸治疗而拔除的牙齿中分离出人牙髓干细胞,并进一步使用免疫磁珠分选对干细胞标志物 CD146 进行富集。通过球培养验证 DPSC 的软骨细胞谱系分化是否由重组转化生长因子 β3(TGFβ3)诱导。由于使用重组蛋白与快速降解和难以在体内给药有关,我们构建了编码人 TGFβ3 的重组腺相关病毒载体,并确定了 DPSCs 的最佳感染复数。转导后的 DPSC 接种在聚-l-乳酸/聚乙二醇(PLLA/PEG)电纺纤维支架上,扫描电子显微镜照片和 CCK-8 细胞计数试剂盒显示细胞附着、增殖和活力良好。将接种有 DPSC 的支架植入裸鼠背部。
转导后的 DPSC 可高表达人 TGFβ3 长达 48 天,并通过免疫组织化学和信使 RNA(mRNA)验证表达软骨细胞标志物胶原 IIa1、Sox9 和聚集蛋白聚糖。TGFβ3/DPSC 构建体(n = 5/组)的免疫组织化学显示具有糖胺聚糖的软骨样基质形成。与未转导的 DPSC 构建体(n = 5/组)相比,体内 TGFβ3/DPSC 构建体显示出更高的胶原 II 和 Sox9 mRNA 表达。Western blot 分析在蛋白质水平上证实了这种表达模式(n = 3/组)。
免疫选择的 DPSC 可以成功地向软骨细胞谱系分化,同时表达软骨诱导因子。接种在 PLLA/PEG 电纺支架上,人 DPSC 形成了三维软骨构建体,这可能对未来治疗软骨缺陷有用。